A beta-1 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Valsartan | Dobutamine may decrease the antihypertensive activities of Valsartan. |
| Ramipril | Dobutamine may decrease the antihypertensive activities of Ramipril. |
| Remikiren | Dobutamine may decrease the antihypertensive activities of Remikiren. |
| Olmesartan | Dobutamine may decrease the antihypertensive activities of Olmesartan. |
| Diltiazem | Dobutamine may decrease the antihypertensive activities of Diltiazem. |
| Minoxidil | Dobutamine may decrease the antihypertensive activities of Minoxidil. |
| Treprostinil | Dobutamine may decrease the antihypertensive activities of Treprostinil. |
| Amlodipine | Dobutamine may decrease the antihypertensive activities of Amlodipine. |
| Nimodipine | Dobutamine may decrease the antihypertensive activities of Nimodipine. |
| Trandolapril | Dobutamine may decrease the antihypertensive activities of Trandolapril. |
| Lercanidipine | Dobutamine may decrease the antihypertensive activities of Lercanidipine. |
| Benazepril | Dobutamine may decrease the antihypertensive activities of Benazepril. |
| Bosentan | Dobutamine may decrease the antihypertensive activities of Bosentan. |
| Enalapril | Dobutamine may decrease the antihypertensive activities of Enalapril. |
| Candoxatril | Dobutamine may decrease the antihypertensive activities of Candoxatril. |
| Losartan | Dobutamine may decrease the antihypertensive activities of Losartan. |
| Moexipril | Dobutamine may decrease the antihypertensive activities of Moexipril. |
| Nitroglycerin | Dobutamine may decrease the antihypertensive activities of Nitroglycerin. |
| Metyrosine | Dobutamine may decrease the antihypertensive activities of Metyrosine. |
| Cryptenamine | Dobutamine may decrease the antihypertensive activities of Cryptenamine. |
| Candesartan cilexetil | Dobutamine may decrease the antihypertensive activities of Candesartan cilexetil. |
| Eprosartan | Dobutamine may decrease the antihypertensive activities of Eprosartan. |
| Quinapril | Dobutamine may decrease the antihypertensive activities of Quinapril. |
| Telmisartan | Dobutamine may decrease the antihypertensive activities of Telmisartan. |
| Irbesartan | Dobutamine may decrease the antihypertensive activities of Irbesartan. |
| Nitrendipine | Dobutamine may decrease the antihypertensive activities of Nitrendipine. |
| Deserpidine | Dobutamine may decrease the antihypertensive activities of Deserpidine. |
| Pentolinium | Dobutamine may decrease the antihypertensive activities of Pentolinium. |
| Trimethaphan | Dobutamine may decrease the antihypertensive activities of Trimethaphan. |
| Captopril | Dobutamine may decrease the antihypertensive activities of Captopril. |
| Bepridil | Dobutamine may decrease the antihypertensive activities of Bepridil. |
| Cilazapril | Dobutamine may decrease the antihypertensive activities of Cilazapril. |
| Saprisartan | Dobutamine may decrease the antihypertensive activities of Saprisartan. |
| Spirapril | Dobutamine may decrease the antihypertensive activities of Spirapril. |
| Mibefradil | Dobutamine may decrease the antihypertensive activities of Mibefradil. |
| Debrisoquine | Dobutamine may decrease the antihypertensive activities of Debrisoquine. |
| Sitaxentan | Dobutamine may decrease the antihypertensive activities of Sitaxentan. |
| Ambrisentan | Dobutamine may decrease the antihypertensive activities of Ambrisentan. |
| Diethylnorspermine | Dobutamine may decrease the antihypertensive activities of Diethylnorspermine. |
| Nilvadipine | Dobutamine may decrease the antihypertensive activities of Nilvadipine. |
| Pinacidil | Dobutamine may decrease the antihypertensive activities of Pinacidil. |
| Temocapril | Dobutamine may decrease the antihypertensive activities of Temocapril. |
| Riociguat | Dobutamine may decrease the antihypertensive activities of Riociguat. |
| Hexamethonium | Dobutamine may decrease the antihypertensive activities of Hexamethonium. |
| Aliskiren | Dobutamine may decrease the antihypertensive activities of Aliskiren. |
| Lacidipine | Dobutamine may decrease the antihypertensive activities of Lacidipine. |
| Manidipine | Dobutamine may decrease the antihypertensive activities of Manidipine. |
| Rauwolfia serpentina root | Dobutamine may decrease the antihypertensive activities of Rauwolfia serpentina root. |
| Selexipag | Dobutamine may decrease the antihypertensive activities of Selexipag. |
| Angiotensin 1-7 | Dobutamine may decrease the antihypertensive activities of Angiotensin 1-7. |
| Imidapril | Dobutamine may decrease the antihypertensive activities of Imidapril. |
| BQ-123 | Dobutamine may decrease the antihypertensive activities of BQ-123. |
| Tetrahydropalmatine | Dobutamine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Dihydralazine | Dobutamine may decrease the antihypertensive activities of Dihydralazine. |
| Zofenopril | Dobutamine may decrease the antihypertensive activities of Zofenopril. |
| Guanoxan | Dobutamine may decrease the antihypertensive activities of Guanoxan. |
| Delapril | Dobutamine may decrease the antihypertensive activities of Delapril. |
| Vincamine | Dobutamine may decrease the antihypertensive activities of Vincamine. |
| Linsidomine | Dobutamine may decrease the antihypertensive activities of Linsidomine. |
| Guanoxabenz | Dobutamine may decrease the antihypertensive activities of Guanoxabenz. |
| Tolonidine | Dobutamine may decrease the antihypertensive activities of Tolonidine. |
| Endralazine | Dobutamine may decrease the antihypertensive activities of Endralazine. |
| Cadralazine | Dobutamine may decrease the antihypertensive activities of Cadralazine. |
| Bietaserpine | Dobutamine may decrease the antihypertensive activities of Bietaserpine. |
| Guanazodine | Dobutamine may decrease the antihypertensive activities of Guanazodine. |
| Methoserpidine | Dobutamine may decrease the antihypertensive activities of Methoserpidine. |
| Guanoclor | Dobutamine may decrease the antihypertensive activities of Guanoclor. |
| Candesartan | Dobutamine may decrease the antihypertensive activities of Candesartan. |
| Dexniguldipine | Dobutamine may decrease the antihypertensive activities of Dexniguldipine. |
| Tocopherylquinone | Dobutamine may decrease the antihypertensive activities of Tocopherylquinone. |
| Benazeprilat | Dobutamine may decrease the antihypertensive activities of Benazeprilat. |
| Fosinoprilat | Dobutamine may decrease the antihypertensive activities of Fosinoprilat. |
| Ramiprilat | Dobutamine may decrease the antihypertensive activities of Ramiprilat. |
| Perindoprilat | Dobutamine may decrease the antihypertensive activities of Perindoprilat. |
| Quinaprilat | Dobutamine may decrease the antihypertensive activities of Quinaprilat. |
| Felodipine | Dobutamine may decrease the antihypertensive activities of Felodipine. |
| Levamlodipine | Dobutamine may decrease the antihypertensive activities of Levamlodipine. |
| Azilsartan medoxomil | Dobutamine may decrease the antihypertensive activities of Azilsartan medoxomil. |
| Diazoxide | Dobutamine may decrease the antihypertensive activities of Diazoxide. |
| Linezolid | The risk or severity of hypertension can be increased when Linezolid is combined with Dobutamine. |
| Benzylpenicilloyl polylysine | Dobutamine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent. |
| Eletriptan | The risk or severity of hypertension can be increased when Eletriptan is combined with Dobutamine. |
| Bethanidine | Dobutamine may decrease the antihypertensive activities of Bethanidine. |
| Zolmitriptan | The risk or severity of hypertension can be increased when Zolmitriptan is combined with Dobutamine. |
| Mirtazapine | The risk or severity of hypertension can be increased when Mirtazapine is combined with Dobutamine. |
| Doxapram | The risk or severity of hypertension can be increased when Doxapram is combined with Dobutamine. |
| Atropine | The risk or severity of hypertension can be increased when Atropine is combined with Dobutamine. |
| Clonidine | Dobutamine may decrease the antihypertensive activities of Clonidine. |
| Guanabenz | Dobutamine may decrease the antihypertensive activities of Guanabenz. |
| Sufentanil | The risk or severity of hypertension can be increased when Sufentanil is combined with Dobutamine. |
| Isoflurane | The risk or severity of hypertension can be increased when Isoflurane is combined with Dobutamine. |
| Alfentanil | The risk or severity of hypertension can be increased when Alfentanil is combined with Dobutamine. |
| Propofol | The risk or severity of hypertension can be increased when Propofol is combined with Dobutamine. |
| Omapatrilat | Dobutamine may decrease the antihypertensive activities of Omapatrilat. |
| Remifentanil | The risk or severity of hypertension can be increased when Dobutamine is combined with Remifentanil. |
| Naratriptan | The risk or severity of hypertension can be increased when Dobutamine is combined with Naratriptan. |
| Frovatriptan | The risk or severity of hypertension can be increased when Dobutamine is combined with Frovatriptan. |
| Methoxyflurane | The risk or severity of hypertension can be increased when Dobutamine is combined with Methoxyflurane. |
| Dutasteride | The risk or severity of hypertension can be increased when Dobutamine is combined with Dutasteride. |
| Halothane | The risk or severity of hypertension can be increased when Dobutamine is combined with Halothane. |